Jibing Liu

1.2k total citations
31 papers, 889 citations indexed

About

Jibing Liu is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Jibing Liu has authored 31 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Hepatology. Recurrent topics in Jibing Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), MicroRNA in disease regulation (4 papers) and Liver Disease and Transplantation (3 papers). Jibing Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), MicroRNA in disease regulation (4 papers) and Liver Disease and Transplantation (3 papers). Jibing Liu collaborates with scholars based in China, United Kingdom and Philippines. Jibing Liu's co-authors include Ming Yang, Nasha Zhang, Huaixin Xing, Yemei Song, Ling Wei, Mengyu Xie, Xingwu Wang, Liyan Lv, Changchun Zhou and Jian Liao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Jibing Liu

29 papers receiving 882 citations

Peers

Jibing Liu
Yi‐Jen Liao Taiwan
Hongchuan Zhao China
Masanori Yoshimatsu Japan
Fazong Wu China
Xiangyong Hao China
Haijun Guo China
Liwei Chen United States
Ratna Kumari India
Annette Hayden United Kingdom
Yi‐Jen Liao Taiwan
Jibing Liu
Citations per year, relative to Jibing Liu Jibing Liu (= 1×) peers Yi‐Jen Liao

Countries citing papers authored by Jibing Liu

Since Specialization
Citations

This map shows the geographic impact of Jibing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibing Liu more than expected).

Fields of papers citing papers by Jibing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jibing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibing Liu. The network helps show where Jibing Liu may publish in the future.

Co-authorship network of co-authors of Jibing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jibing Liu. A scholar is included among the top collaborators of Jibing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jibing Liu. Jibing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xiaomei, Minmin Shi, Yuting Dai, et al.. (2025). TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC. Cell & Bioscience. 15(1). 17–17.
2.
3.
Ma, Yue, et al.. (2024). Molecular Detection and Characterization of Cryptosporidium spp. and Giardia duodenalis in Dairy Calves from Ningxia, China. Acta Parasitologica. 69(4). 1876–1885. 2 indexed citations
4.
Ma, Xiangyu, et al.. (2023). Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium. Journal of Hepatocellular Carcinoma. Volume 10. 1511–1525. 15 indexed citations
5.
Liu, Lei, Jia Wu, Minxin Shi, et al.. (2022). New Metabolic Alterations and a Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma. Genomics Proteomics & Bioinformatics. 20(4). 670–687. 15 indexed citations
6.
Liu, Jibing, Zhijuan Wu, Jianxin Zhang, et al.. (2021). Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism. Medicine. 100(26). e26441–e26441. 5 indexed citations
7.
Liu, Jiandong, Jianyuan Zhou, Nasha Zhang, et al.. (2021). N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization. Archives of Toxicology. 95(5). 1621–1629. 26 indexed citations
8.
Dong, Hong, Li Zheng, Haiyan Yang, et al.. (2021). Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma. Journal of Cancer Research and Therapeutics. 17(3). 784–789. 5 indexed citations
9.
Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer. 18(1). 147–147. 246 indexed citations
10.
Xiong, Xiangyu, Jupeng Yuan, Nasha Zhang, et al.. (2019). Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis. Biochemical and Biophysical Research Communications. 521(2). 478–484. 26 indexed citations
11.
Pan, Wenting, Nasha Zhang, Wenjuan Liu, et al.. (2018). The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8. Journal of Biological Chemistry. 293(44). 17154–17165. 44 indexed citations
12.
Yuan, Jupeng, Nasha Zhang, Hui Zhu, et al.. (2017). CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer. Scientific Reports. 7(1). 11802–11802. 8 indexed citations
13.
Shi, Meng, Fei Ma, Jibing Liu, et al.. (2017). A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy. Breast Cancer Research and Treatment. 166(1). 109–116. 9 indexed citations
14.
Liu, Jibing, et al.. (2014). miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma. Tumor Biology. 36(1). 219–225. 48 indexed citations
15.
16.
Li, Hui, Fei Pei, Jingzhou Chen, et al.. (2014). Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients. BMC Cardiovascular Disorders. 14(1). 136–136. 31 indexed citations
17.
Liu, Jibing, Xiaohu Tang, Meng Li, et al.. (2013). Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Research and Treatment. 140(1). 151–157. 43 indexed citations
18.
Liu, Lei, Zhiwei Wang, Jibing Liu, et al.. (2013). Perioperative Allogenenic Blood Transfusion Is Associated with Worse Clinical Outcomes for Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE. 8(5). e64261–e64261. 96 indexed citations
19.
20.
Zhou, Changchun, Jibing Liu, Yang Li, et al.. (2011). microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma. FEBS Letters. 585(12). 1828–1834. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Jen Liao Breakdown of academic impact, for papers by Hongchuan Zhao Breakdown of academic impact, for papers by Masanori Yoshimatsu Breakdown of academic impact, for papers by Fazong Wu Breakdown of academic impact, for papers by Xiangyong Hao Breakdown of academic impact, for papers by Haijun Guo Breakdown of academic impact, for papers by Liwei Chen Breakdown of academic impact, for papers by Ratna Kumari Breakdown of academic impact, for papers by Annette Hayden
Rankless by CCL
2026